In 2014, a neuregulin 1 (NRG1) fusion was identified for the first time in NSCLC, when five CD74-NRG1 fusions were detected among invasive mucinous adenocarcinoma patients [241]. The gene discussed is CD74; the disease is non-small cell lung carcinoma.